Delivery Order SPE2DB20D3103-SPE2DB24FM0T3
Award Date
12/27/23
Potential Completion Date
12/28/23
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,027.93, is for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a local anesthetic medication. The $3,635.91 Firm Fixed Price contract is a Delivery Order that has an ultimate completion date of April 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award, with ID SPE2DX15D1104|SPE2DX24F3FH9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,037.22 firm fixed-price delivery order is for the pharmaceutical product XYLOCAINE-MPF 2% VIAL 5ML, with an ultimate completion date of October 27, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award is for the delivery of XYLOCAINE-MPF 1% VIAL 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,484 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,360.00 firm fixed-price delivery order (SPE2DB20D3103|SPE2DB24FQ1W8) is for the supply of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a prescription medication. The contract has a completion date of September 9, 2024 and was awarded on September 6, 2024. There is no set-aside designation for this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.11 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product, with a period of performance ending on October 31, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XYLOCAINE-MPF 1%-EPI 1:200,000 30ML. The fixed-price delivery order, valued at $2,139.08, has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00....
This federal contract award is for the delivery of Xylocaine-MPF 2% Vial 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price delivery order contract. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,367.62 and an ultimate completion date of November 7, 2022. The award was made on November 4, 2022. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award is for the delivery of XYLOCAINE-MPF 2% VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,741.42, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary...
This federal contract award, valued at $12,107.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. The contract provides for the delivery of XYLOCAINE 1%-EPI 1:100,000 50ML, a pharmaceutical...